Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Summit Therapeutics PLC
SMMTCurrent price
29.48 USD
-3.04 USD (-9.35%)
Last closed
31.93 USD
Company
www.summittxinc.com
ISIN
US86627T1088
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
23 465 037 824 USD
Yield for 12 month
+1 528.73 %
1Y
3Y
5Y
10Y
15Y
SMMT
Summit Therapeutics Inc., a biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies in the United States, and the United Kingdom. The company's lead development candidate is Ivonescimab, a bispecific antibody for immunotherapy through blockade of PD-1 with the anti-angiogenesis; and anti-infectives portfolio includes SMT-738, a novel class of precision antibiotics for the treatment of multidrug resistant infections, which primarily includes carbapenem-resistant Enterobacteriaceae infections. It has a collaboration and license agreement with Akeso, Inc. and its affiliates to develop and commercialize ivonescimab, as well as strategic collaboration with The University of Texas MD Anderson Cancer Center for the purpose of accelerating the development of ivonescimab. The company was founded in 2003 and is headquartered in Miami, Florida. Address: 601 Brickell Key Drive, Miami, FL, United States, 33131
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
19.75 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
+704 295 USD
Current Quarter
–
Last Quarter
–
Current Year
-2 050 000 USD
Last Year
-1 809 705 USD
Current Quarter
-20 000 USD
Last Quarter
-27 000 USD
Key Figures SMMT
1 year
3 years
5 years
10 years
EBITDA
-143 592 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-31.01 %
PEG Ratio
–
Return On Equity TTM
-102.77 %
Wall Street Target Price
19.75 USD
Revenue TTM
–
Book Value
0.27 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-100 %
Dividend Yield
–
Gross Profit TTM
705 000 USD
Earnings per share
-0.11 USD
Diluted Eps TTM
-0.11 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics SMMT
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History SMMT
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:1
Payout Ratio
–
Last Split Date
21.09.2020
Dividend Date
–
Stock Valuation SMMT
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
6425.2766
Price Sales TTM
753.9008
Enterprise Value EBITDA
-5.3247
Price Book MRQ
120.2873
Financials SMMT
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators SMMT
For 52 weeks
1.64 USD
33.89 USD
50 Day MA
12.21 USD
Shares Short Prior Month
17 256 730
200 Day MA
6.35 USD
Short Ratio
10.58
Shares Short
18 230 707
Short Percent
17.22 %
BeatStart